SCHEMBL18157765

SCHEMBL18157765

C(=C/c1c(/C=C/c2ccccn2)[nH]c2ccccc12)\c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.50
KMT2A Q03164 7/20 0.47
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
MEN1 O00255 6/20 0.47
MAPT P10636 4/20 0.47
KDM4E B2RXH2 3/20 0.47
ATM Q13315 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
GLA P06280 1/20 0.47
MAPK1 P28482 1/20 0.47
PLK4 O00444 1/20 0.42
PADI4 Q9UM07 1/20 0.41
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
ALPG P10696 1/20 0.41
HTT P42858 1/20 0.41
FGFR1 P11362 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18157747 1.00 ALK (0.50) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157756 0.93 KMT2A (0.52) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157755 0.87 NPC1 (0.50) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL28555372 0.87 NPC1 (0.50) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157762 0.84 ALK (0.50) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157745 0.84 PLK4 (0.43) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL18160331 0.81 MAPT (0.47) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL20223300 0.81 CYP11B1 (0.58) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157780 0.79 PADI4 (0.41) ALKKMT2ANPC1RAB9AMEN1
SCHEMBL18157735 0.78 NPC1 (0.50) ALKKMT2ANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION (US) 2019-03-26 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
WO-2016172193-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH RESEARCH FOUNDATION (US) 2016-10-27 WO disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents XPA, PPOX, ALAD ALK 4816/4885KMT2A 2258/4885NPC1 1892/4885
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD ALK 4816/4885KMT2A 2258/4885NPC1 1892/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD ALK 4816/4885KMT2A 2258/4885NPC1 1892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.